Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma

Bisphosphonate therapy has been shown to significantly reduce the incidence of skeletal complications in patients with myeloma. Several recent reports have described osteonecrosis of the jaw (ONJ) associated with bisphosphonates. These reports mainly demonstrate an association between ONJ and potent i.v. bisphosphonates. We report a case of ONJ in a patient with myeloma, who had only been treated with oral sodium clodronate. While the degree of risk for osteonecrosis in patients taking oral bisphosphonates, such as clodronate, remains uncertain it would be prudent to consider carefully the indications for the use of these agents to minimise the risk of ONJ.

[1]  N. Nikitakis,et al.  Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases. , 2007, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[2]  P. Aspenberg.  Osteonecrosis of the jaw: what do bisphosphonates do? , 2006, Expert opinion on drug safety.

[3]  E. Terpos,et al.  Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single‐centre experience in 303 patients , 2006, British journal of haematology.

[4]  P. L. Bergsagel,et al.  Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. , 2006, Mayo Clinic proceedings.

[5]  M. Cova,et al.  Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. , 2006, Dento maxillo facial radiology.

[6]  L. Elting,et al.  Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. , 2006, The Lancet. Oncology.

[7]  J. Kalmar,et al.  Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws , 2006, Annals of Internal Medicine.

[8]  D. Samson,et al.  Guidelines on the diagnosis and management of multiple myeloma 2005 , 2006, British journal of haematology.

[9]  L. Pour,et al.  [Osteonecrosis of the jaw in the course of multiple myeloma treatment and bisphosphonate administration]. , 2006, Vnitrni lekarstvi.

[10]  J. Kalmar,et al.  Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. , 2006, Annals of internal medicine.

[11]  J. A. Aguirre Urízar,et al.  Bisphosphonates and oral pathology II. Osteonecrosis of the jaws: review of the literature before 2005. , 2006, Medicina oral, patologia oral y cirugia bucal.